NCT04693884View on ClinicalTrials.gov

Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

April 16, 2025

Study Completion Date

April 16, 2025

Conditions
CannabisCardiovascular Risk Factor
Interventions
DRUG

Cannabis

Cannabis of (\~10% THC concentration \<1% CBD concentration) will be smoked.

DRUG

Cannabis

Cannabis of (\~10% THC concentration \<1% CBD concentration) will be vaporized.

DRUG

Cannabis

Cannabis of (\~10% CBD concentration \<1% THC concentration) will be smoked.

DRUG

Cannabis

Cannabis of (\~10% CBD concentration \<1% THC concentration) will be vaporized.

Trial Locations (1)

N1G2W1

University of Guelph, Guelph

All Listed Sponsors
lead

Jamie Burr

OTHER

NCT04693884 - Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise | Biotech Hunter | Biotech Hunter